Matches in Wikidata for { <http://www.wikidata.org/entity/Q98390095> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q98390095 description "2020 թվականի օգոստոսի 10-ին հրատարակված գիտական հոդված" @default.
- Q98390095 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q98390095 description "im August 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q98390095 description "scientific article published on 10 August 2020" @default.
- Q98390095 description "wetenschappelijk artikel" @default.
- Q98390095 description "наукова стаття, опублікована 10 серпня 2020" @default.
- Q98390095 name "Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab" @default.
- Q98390095 name "Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab" @default.
- Q98390095 type Item @default.
- Q98390095 label "Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab" @default.
- Q98390095 label "Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab" @default.
- Q98390095 prefLabel "Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab" @default.
- Q98390095 prefLabel "Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab" @default.
- Q98390095 P1433 Q98390095-0F9392A4-196B-4F5D-9ED6-E54E262EEE07 @default.
- Q98390095 P1476 Q98390095-C2E7DFC8-B53B-4597-9329-7C98C0511FCF @default.
- Q98390095 P2093 Q98390095-5F53B664-864F-4D79-9DDE-5EA105005B63 @default.
- Q98390095 P2093 Q98390095-692932FE-9F10-4D64-AD46-2947CBF3C8B5 @default.
- Q98390095 P2093 Q98390095-6B6AD502-734E-49DD-AB31-4D07681D29F8 @default.
- Q98390095 P2093 Q98390095-705B23B0-EFC5-4BEB-BD9C-E46C602DE49F @default.
- Q98390095 P2093 Q98390095-753E8752-44DF-4010-ACC8-EDDD615D32DA @default.
- Q98390095 P2093 Q98390095-75533695-E975-4D84-9090-33A689A08517 @default.
- Q98390095 P2093 Q98390095-96C3A4AF-7EF7-4FB8-AEDD-1869F851054D @default.
- Q98390095 P2093 Q98390095-BDCB7EDD-963B-42C9-A92F-7A1C30A4D545 @default.
- Q98390095 P2093 Q98390095-D95E6623-5F9E-4C70-860C-1DE14B073894 @default.
- Q98390095 P2093 Q98390095-EDA63BF9-E0C9-47EC-978B-A37498859D31 @default.
- Q98390095 P275 Q98390095-b7edfac6-5bd2-4652-bac4-76d9ef61c01d @default.
- Q98390095 P31 Q98390095-15307782-1CBD-4545-AD71-056C5E92FC32 @default.
- Q98390095 P356 Q98390095-FD13B715-EF95-4DF9-8005-4CD2369DB5D8 @default.
- Q98390095 P433 Q98390095-2A265FE1-9372-4E45-9139-A73825F4776E @default.
- Q98390095 P478 Q98390095-84117939-53C0-445D-A175-08AAEC5CB63F @default.
- Q98390095 P50 Q98390095-1CD68460-D574-4A4E-95FE-82116A628F7A @default.
- Q98390095 P50 Q98390095-8D1F110B-6498-41B3-AEB4-AC4BAA64C5C3 @default.
- Q98390095 P50 Q98390095-943B16B5-A2AA-4034-B209-01AEDD39134F @default.
- Q98390095 P577 Q98390095-7BFDDF44-D13F-4CEA-B9A7-B49264797C8F @default.
- Q98390095 P6216 Q98390095-f46d72d0-bf31-441b-b15b-934b6c540f6b @default.
- Q98390095 P698 Q98390095-2913B793-B98E-4BAB-974F-CE7906CE9CDF @default.
- Q98390095 P921 Q98390095-35CD552F-8713-4884-8E19-74313E04B575 @default.
- Q98390095 P921 Q98390095-6DF857B1-60EB-461A-8799-D4FF988FC773 @default.
- Q98390095 P921 Q98390095-76A359C3-DA8D-41E1-8501-9C10D8F8675D @default.
- Q98390095 P356 CANCERS12082234 @default.
- Q98390095 P698 32785166 @default.
- Q98390095 P1433 Q27722963 @default.
- Q98390095 P1476 "Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab" @default.
- Q98390095 P2093 "Etienne Giroux-Leprieur" @default.
- Q98390095 P2093 "Gérald Bonardel" @default.
- Q98390095 P2093 "Jean-Baptiste Assié" @default.
- Q98390095 P2093 "Laurence Champion" @default.
- Q98390095 P2093 "Lucas Goldfarb" @default.
- Q98390095 P2093 "Margot Playe" @default.
- Q98390095 P2093 "Marie-Ange Massiani" @default.
- Q98390095 P2093 "Michael Soussan" @default.
- Q98390095 P2093 "Nicolas Girard" @default.
- Q98390095 P2093 "Romain-David Seban" @default.
- Q98390095 P275 Q20007257 @default.
- Q98390095 P31 Q13442814 @default.
- Q98390095 P356 "10.3390/CANCERS12082234" @default.
- Q98390095 P433 "8" @default.
- Q98390095 P478 "12" @default.
- Q98390095 P50 Q57027992 @default.
- Q98390095 P50 Q59548589 @default.
- Q98390095 P50 Q85567091 @default.
- Q98390095 P577 "2020-08-10T00:00:00Z" @default.
- Q98390095 P6216 Q50423863 @default.
- Q98390095 P698 "32785166" @default.
- Q98390095 P921 Q13896859 @default.
- Q98390095 P921 Q1427096 @default.
- Q98390095 P921 Q3658562 @default.